Could a ketone drink calm the bipolar brain?

NCT ID NCT06373016

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looks at how two types of energy—glucose and ketones—change brain activity and behavior in people with bipolar disorder. Participants will have MRI scans while playing money-winning games, before and after drinking either glucose or ketones. Researchers will compare results between people with bipolar disorder and healthy volunteers to understand how the brain uses energy differently.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Glucose and ketone drinks
What this could lead to
If successful, this could reveal how diet-based energy sources like ketones might stabilize brain networks in bipolar disorder, pointing toward future dietary or metabolic therapies.
What could go wrong
This is an early-stage observational study with only 100 participants, not a treatment trial. Results may not lead to direct clinical changes or apply to all people with bipolar disorder.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BIPOLAR DISORDER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Laufer Center for Physical and Quantitative Biology , Stony Brook University

    ACTIVE_NOT_RECRUITING

    Stony Brook, New York, 11794, United States

  • Martinos Center for Biomedical Research, Building 149, 13th Street

    RECRUITING

    Charlestown, Massachusetts, 02129, United States

  • McLean Hospital

    RECRUITING

    Belmont, Massachusetts, 02478, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.